🇺🇸 Insulin glargine plus insulin analogues in United States

Insulin glargine plus insulin analogues (Insulin glargine plus insulin analogues) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Insulin glargine plus insulin analogues in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Insulin glargine plus insulin analogues approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Insulin glargine plus insulin analogues in United States?

IRCCS San Raffaele is the originator. The local marketing authorisation holder may differ — check the official source linked above.